![]() | ![]() |
![]() | |
Verfasst von: | Pazan, Farhad [VerfasserIn] ![]() |
Burkhardt, Heinrich [VerfasserIn] ![]() | |
Wehling, Martin [VerfasserIn] ![]() | |
Titel: | A systematic review of the current evidence from randomised controlled trials on the impact of medication optimisation or pharmacological interventions on quantitative measures of cognitive function in geriatric patients |
Verf.angabe: | Farhad Pazan, Mirko Petrovic, Antonio Cherubini, Alfonso J. Cruz-Jentoft, Michael Denkinger, Tischa J. M. van der Cammen, Jennifer M. Stevenson, Kinda Ibrahim, Chakravarthi Rajkumar, Marit Stordal Bakken, Peter Crome, Adalsteinn Guðmundsson, Wilma Knol, Birgitta M. G. Snijders, Denis O’Mahony, José Antonio Serra-Rexach, George Soulis, Rob J. van Marum, Gijsbertus Ziere, Alpana Mair, Heinrich Burkhardt, Agnieszka Neumann-Podczaska, Katarzyna Wieczorowska-Tobis, Marilia Andreia Fernandes, Heidi Gruner, Nathalie van der Velde, Martin Wehling |
E-Jahr: | 2022 |
Jahr: | 26 October 2022 |
Umfang: | 12 S. |
Fussnoten: | Gesehen am 31.01.2023 |
Titel Quelle: | Enthalten in: Drugs & aging |
Ort Quelle: | Berlin [u.a.] : Springer, 1991 |
Jahr Quelle: | 2022 |
Band/Heft Quelle: | 39(2022), 11 vom: Okt., Seite 863-874 |
ISSN Quelle: | 1179-1969 |
Abstract: | Cognitive decline is common in older people. Numerous studies point to the detrimental impact of polypharmacy and inappropriate medication on older people’s cognitive function. Here we aim to systematically review evidence on the impact of medication optimisation and drug interventions on cognitive function in older adults. |
DOI: | doi:10.1007/s40266-022-00980-9 |
URL: | kostenfrei: Volltext: https://doi.org/10.1007/s40266-022-00980-9 |
DOI: https://doi.org/10.1007/s40266-022-00980-9 | |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1832824551 |
Verknüpfungen: | → Zeitschrift |
Lokale URL UB: | ![]() |